Gender and duration of untreated psychosis: A systematic review and meta-analysis

Early Intervention in Psychiatry

Volumn 6, Issue 2, 2012, Pages 115-127

  Cascio, Maria Teresa ^a   Cella, Matteo ^c,d   Preti, Antonio ^a,b   Meneghelli, Anna ^a   Cocchi, Angelo ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b Genneruxi Medical Center   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Early intervention; Gender; Meta analysis; Psychosis; Schizophrenia

Indexed keywords

ADULT; AGE DISTRIBUTION; CONSULTATION; DISEASE COURSE; DURATION OF UNTREATED PSYCHOSIS; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MEDLINE; PRIORITY JOURNAL; PSYCINFO; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SEX DIFFERENCE; SYSTEMATIC REVIEW;

AGE OF ONSET; HUMANS; INCIDENCE; PSYCHOTIC DISORDERS; SEX CHARACTERISTICS; TIME FACTORS;

EID: 84859923505     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/j.1751-7893.2012.00351.x     Document Type: Review

References (85)

1. Altamura AC, Bassetti R, Bignotti S, Pioli R, Mundo E. Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study. Schizophr Res 2003; 60: 47-55.
2. Beiser M, Erickson D, Fleming JA, Iacono WG. Establishing the onset of psychotic illness. Am J Psychiatry 1993; 150: 1349-54.
3. Jackson D, Lawoyin R, Gaynor K etal. Is the duration of untreated psychosis temporally stable? Eur Psychiatry 2008; 23: 97-9.
4. Marvin R, Rosen C, Reilly JL, Solari H, Sweeney JA. Diagnostic and gender differences in first episode psychosis. Schizophr Bull 2007; 33: 241.
5. Leung A, Chue P. Sex differences in schizophrenia: a review of the literature. Acta Psychiatr Scand 2000; 401 (Suppl.): 3-38.
6. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 2008; 30: 67-76.
7. Beauchamp G, Gagnon A. Influence of diagnostic classification on gender ratio in schizophrenia. A meta-analysis of youths hospitalized for psychosis. Soc Psychiatry Psychiatr Epidemiol 2004; 39: 1017-22.
8. Heilä H, Haukka J, Suvisaari J, Lönnqvist J. Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med 2005; 35: 725-32.
9. Joukamaa M, Heliövaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V. Mental disorders and cause-specific mortality. Br J Psychiatry 2001; 179: 498-502.
10. Cocchi A, Meneghelli A, Preti A. 'Programma 2000': celebrating ten years of activity of an Italian pilot program on early intervention in psychosis. Aust N Z J Psychiatry 2008; 42: 1003-12.
11. Cotton SM, Lambert M, Schimmelmann BG etal. Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis. Schizophr Res 2009; 114: 17-24.
12. Häfner H, Nowotny B. Loffler W, an der Heiden W, Maurer K. When and how does schizophrenia produce social deficits. Eur Arch Psychiatry Clin Neurosci 1995; 246: 17-28.
13. Morgan VA, Castle DJ, Jablensky AV. Do women express and experience psychosis differently from men? Epidemiological evidence from the Australian National Study of Low Prevalence (Psychotic) Disorder. Aust N Z J Psychiatry 2008; 42: 74-82.
14. Larsen TK, McGlashan TH, Moe LC. First-episode schizophrenia. 1. Early course parameters. Schizophr Bull 1996; 22: 241-56.
15. Thomas SP, Nandhra HS. Early intervention in psychosis: a retrospective analysis of clinical and social factors influencing duration of untreated psychosis. Prim Care Companion J Clin Psychiatry 2009; 11: 212-14.
16. Thorup A, Petersen L, Jeppesen P etal. Gender differences in young adults with first-episode schizophrenia spectrum disorders at baseline in the Danish OPUS study. J Nerv Ment Dis 2007; 195: 396-405.
17. Køster A, Lajer M, Lindhardt A, Rosenbaum B. Gender differences in first episode psychosis. Soc Psychiatry Psychiatr Epidemiol 2008; 43: 940-6.
18. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and in cohorts of first-episode outcome patients - a systematic review. Arch Gen Psychiatry 2005; 62: 975-83.
19. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 2005; 162: 1785-804.
20. Lappin JM, Morgan K, Morgan C etal. Gray matter abnormalities associated with duration of untreated psychosis. Schizophr Res 2006; 83: 145-53.
21. Malla AK, Bodnar M, Joober R, Lepage M. Duration of untreated psychosis is associated with orbital-frontal grey matter volume reductions in first episode psychosis. Schizophr Res 2011; 125: 13-20.
22. Moncrieff J. Questioning the 'neuroprotective' hypothesis: does drug treatment prevent brain damage in early psychosis or schizophrenia? Br J Psychiatry 2011; 198: 85-7.
23. Lambert M, Conus P, Lubman DI etal. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand 2005; 112: 141-8.
24. Yung AR, Buckby JA, Cosgrave EM etal. Association between psychotic experiences and depression in a clinical sample over 6months. Schizophr Res 2007; 91: 246-53.
25. de Haan L, Welborn K, Krikke M etal. Opinions of mothers on the first psychotic episode and the start of treatment of their child. Eur Psychiatry 2004; 19: 226-9.
26. Chong SA, Mythily Lum A, Chan YH, McGorry P. Determinants of duration of untreated psychosis and the pathway to care in Singapore. Int J Soc Psychiatry 2005; 51: 55-62.
27. Skeate A, Jackson C, Birchwood M etal. Duration of untreated psychosis and pathways to care in first-episode psychosis. Investigation of help-seeking behaviour in primary care. Br J Psychiatry 2002; 43 (Suppl. 43): s73-7.
28. Morgan C, Abdul-Al R, Lappin JM etal. Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study. Br J Psychiatry 2006; 189: 446-52.
29. Nishii H, Yamazawa R, Shimodera S, Suzuki M, Hasegawa T, Mizuno M. Clinical and social determinants of a longer duration of untreated psychosis of schizophrenia in a Japanese population. Early Interv Psychiatry 2010; 4: 182-8.
30. Edwards J, McGorry PD, Waddell FM etal. Enduring negative symptoms in first-episode psychosis: comparison of six methods using follow-up data. Schizophr Res 1999; 40: 147-58.
31. Malla AK, Takhar JJ, Norman RM etal. Negative symptoms in first episode non-affective psychosis. Acta Psychiatr Scand 2002; 105: 431-9.
32. Verdoux H, Bergey C, Assens F etal. Prediction of duration of psychosis before first admission. Eur Psychiatry 1998; 13: 346-52.
33. Cocchi A, Mapelli V, Meneghelli A, Preti A. Cost-effectiveness of treating first episode psychosis. Five-year follow-up results from an Italian early intervention program. Early Interv Psychiatry 2011; 5: 203-11.
34. Galdas PM, Cheater F, Marshall P. Men and health helpseeking behaviour: literature review. J Adv Nurs 2005; 49: 616-23.
35. Kessler RC, Brown RL, Broman CL. Sex differences in psychiatric help-seeking: evidence from four large-scale surveys. J Health Soc Behav 1981; 22: 49-64.
36. Eisenberg D, Downs MF, Golberstein E, Zivin K. Stigma and help seeking for mental health among college students. Med Care Res Rev 2009; 66: 522-41.
37. Schimmelmann BG, Huber CG, Lambert M, Cotton S, McGorry PD, Conus P. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. J Psychiatr Res 2008; 42: 982-90.
38. Kleinhaus K, Harlap S, Perrin M etal. Age, sex and first treatment of schizophrenia in a population cohort. J Psychiatr Res 2011; 45: 136-41.
39. Degenhardt L, Chiu WT, Sampson N etal. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med 2008; 5: e141.
40. Dragt S, Nieman DH, Becker HE etal. Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. Can J Psychiatry 2010; 55: 165-71.
41. González-Pinto A, Vega P, Ibáñez B etal. Impact of cannabis and other drugs on age at onset of psychosis. J Clin Psychiatry 2008; 69: 1210-16.
42. Sugranyes G, Flamarique I, Parellada E etal. Cannabis use and age of diagnosis of schizophrenia. Eur Psychiatry 2009; 24: 282-6.
43. Larsen TK, Melle I, Auestad B etal. Substance abuse in first-episode non-affective psychosis. Schizophr Res 2006; 88: 55-62.
44. Grossman LS, Harrow M, Rosen C, Faull R, Strauss GP. Sex differences in schizophrenia and other psychotic disorders: a 20-year longitudinal study of psychosis and recovery. Compr Psychiatry 2008; 49: 523-9.
45. Haro JM, Novick D, Bertsch J, Karagianis J, Dossenbach M, Jones PB. Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study. Br J Psychiatry 2011; 199: 194-201.
46. Large M, Nielssen O, Slade T, Harris A. Measurement and reporting of the duration of untreated psychosis. Early Interv Psychiatry 2008; 2: 201-11.
47. Large M, Nielssen O. Gender differences in the duration of untreated psychosis (Letter to the Editor). J Nerv Ment Dis 2008; 196: 171-2.
48. Large M, Farooq S, Nielssen O, Slade T. Relationship between gross domestic product and duration of untreated psychosis in low- and middle-income countries. Br J Psychiatry 2008; 193: 272-8.
49. Higgins JP, Thompson SG, Deeks JJ etal. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
50. Egger M, Davey Smith G, Schneider M etal. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
51. Duval S, Tweedie R. A nonparametric 'trim and fill' method of accounting for publication bias in meta-analysis. J Am Stat Assoc 2000; 95: 89-98.
52. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
53. Rosenthal R. The 'file drawer problem' and tolerance for null results. Psychol Bull 1979; 86: 638-41.
54. Rosenthal R. Meta-Analytic Procedures for Social Research. Newbury Park, CA: Sage, 1991.
55. Cohen RZ, Gotowiec A, Seeman MV. Duration of pretreatment phases in schizophrenia: women and men. Can J Psychiatry 2000; 45: 544-7.
56. Fresán A, Apiquian R, Ulloa RE, Loyzaga C, Nicolini H, Gómez L. Premorbid functioning by gender and its relationship with duration of untreated psychosis in first psychotic episode. (Article in Spanish). Actas Esp Psiquiatr 2003; 31: 53-8.
57. Gangadhar BN, Panner Selvan C, Subbakrishna DK, Janakiramaiah N. Age-at-onset and schizophrenia: reversed gender effect. Acta Psychiatr Scand 2002; 105: 317-19.
58. Gorwood P, Leboyer M, Jay M, Payan C, Feingold J. Gender and age at onset in schizophrenia: impact of family history. Am J Psychiatry 1995; 152: 208-12.
59. Gureje O. Gender and schizophrenia: age at onset and sociodemographic attributes. Acta Psychiatr Scand 1991; 83: 402- 5.
60. Ho BC, Andreasen NC, Flaum M, Nopoulos P, Miller D. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry 2000; 157: 808-15.
61. Larsen TK, McGlashan TH, Johannessen JO etal. Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatment. Am J Psychiatry 2001; 158: 1917-19.
62. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992; 149: 1183-8.
63. Loranger AW. Sex difference in age at onset of schizophrenia. Arch Gen Psychiatry 1984; 41: 157-61.
64. Malla AK, Norman RM, Manchanda R etal. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res 2002; 54: 231-42.
65. Murthy GV, Janakiramaiah N, Gangadhar BN, Subbakrishna DK. Sex difference in age at onset of schizophrenia: discrepant findings from India. Acta Psychiatr Scand 1998; 97: 321-5.
66. Naqvi HA Hussain S, Zaman M, Islam M. Pathway to care: duration of untreated psychosis from Karachi, Pakistan. PLoS ONE 2009; 4: e7409.
67. Oosthuizen P, Emsley RA, Keyter N, Niehaus DJ, Koen L. Duration of untreated psychosis and outcome in first-episode psychosis. Perspective from a developing country. Acta Psychiatr Scand 2005; 111: 214-19.
68. Pek E, Mythily S, Chong SA. Clinical and social correlates of duration of untreated psychosis in first-episode psychosis patients. Ann Acad Med Singapore 2006; 35: 24-6.
69. Penttilä M, Jääskeläinen E, Haapea M etal. Association between duration of untreated psychosis and brain morphology in schizophrenia within the Northern Finland 1966 Birth Cohort. Schizophr Res 2010; 123: 145-52.
70. Perkins D, Lieberman J, Gu H etal. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry 2004; 185: 18-24.
71. Preston NJ, Stirling ML, Perera K etal. A statewide evaluation system for early psychosis. Aust N Z J Psychiatry 2003; 37: 421-8.
72. Tang YL, Sevigny R, Mao PX, Jiang F, Cai Z. Help-seeking behaviors of Chinese patients with schizophrenia admitted to a psychiatric hospital. Adm Policy Ment Health 2007; 34: 101-7.
73. Üçok A, Polat A, Genc A, Cakir S, Turan N. Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia. J Psychiatr Res 2004; 38: 163-8.
74. Wunderink A, Nienhuis FJ, Sytema S, Wiersma D. Treatment delay and response rate in first episode psychosis. Acta Psychiatr Scand 2006; 113: 332-9.
75. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria for a Selected Group of Functional Disorders, 3rd edn. New York, NY: Biometrics Research Division, New York State Psychiatric Institute, 1977.
76. Singh S. Outcome measures in early psychosis. Relevance of duration of untreated psychosis. Br J Psychiatry 2007; 191 (Suppl. 50): S58-63.
77. Singh S, Grange T. Measuring pathways to care in first-episode psychosis: a systematic review. Schizophr Res 2006; 81: 75-82.
78. Oliveira AM, Menezes PR, Busatto GF, McGuire PK, Murray RM, Scazufca M. Family context and duration of untreated psychosis (DUP): results from the Sao Paulo Study. Schizophr Res 2010; 119: 124-30.
79. McGorry PD, Nelson B, Amminger GP etal. Intervention in individuals at ultra high risk for psychosis: a review and future directions. J Clin Psychiatry 2009; 70: 1206-12.
80. Haas GL, Sweeney JA. Premorbid and onset features of first-episode schizophrenia. Schizophr Bull 1992; 18: 373-86.
81. Keshavan MS, Schooler NR. First-episode studies in schizophrenia: criteria and characterization. Schizophr Bull 1992; 18: 491-513.
82. Amminger GP, Schäfer MR, Papageorgiou K etal. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2010; 67: 146-54.
83. Preti A, Cella M. Randomized controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophr Res 2010; 123: 30-6.
84. McGorry PD. Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more eff ective treatment in psychiatry. Am J Psychiatry 2007; 164: 859-60.
85. Raballo A, Larøi F. Clinical staging: a new scenario for the treatment of psychosis. Lancet 2009; 374: 365-7.